Feb 10 2023 This Week in Cardiology Podcast

This Week in Cardiology

Medscape Podcasts

Medicine, Science, Health & Fitness

4.9 • 963 Ratings

🗓️ 10 February 2023

⏱️ 22 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Drug and non-drug therapies for HFpEF, the search for AF, and exercise as medicine are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic

I. SGLT2 Inhibitors in HFpEF

Dapagliflozin Gets Expanded Heart Failure Indication in Europe https://www.medscape.com/viewarticle/988034

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction https://www.nejm.org/doi/full/10.1056/NEJMoa2206286

II. HFpEF and Heart Rate

Accelerated Pacing a Possible Strategy for Preserved-EF Heart Failure? https://www.medscape.com/viewarticle/987815

III. Stroke and AF

STROKE AF at 3 Years: High AF Rate After Atherosclerotic Stroke https://www.medscape.com/viewarticle/988076

Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease https://jamanetwork.com/journals/jama/fullarticle/2780490
Cryptogenic Stroke and Underlying Atrial Fibrillation https://www.nejm.org/doi/full/10.1056/nejmoa1313600
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT https://pubmed.ncbi.nlm.nih.gov/28329139/
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke https://www.nejm.org/doi/full/10.1056/NEJMoa2101897

IV. Exercise as Medicine

Trending Clinical Topic: Exercise Prescription https://reference.medscape.com/viewarticle/985373

Effect of Moderate and Vigorous Aerobic Exercise on Incident Diabetes in Adults With Obesityhttps://pubmed.ncbi.nlm.nih.gov/36716009/

Features

Could a Breakthrough in Heart Failure With Preserved Ejection Fraction Just Take a Change of Pace? https://www.medscape.com/viewarticle/988088

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Transcript

Click on a timestamp to play from that location

0:00.0	You're listening to this week in cardiology from the heart
0:03.4	org medscape cardiology this podcast is intended for health care
0:07.6	professionals only any views expressed are the presenters own and do not
0:11.2	necessarily reflect the views of WebMD or Medscape.
0:15.1	You can now access the latest in medical news on your Amazon Alexa-enabled device.
0:19.7	Join me, Perry Wilson, every weekday morning for Medscape Medical Minute where I
0:23.7	highlight the top medical stories of the day. To add Medscape Medical
0:27.4	Minute to your flash briefing search for Medscape Medical Minute on Amazon and
0:31.5	click enable or open the Amazon Alexa app go to skills
0:34.7	search for Medscape Medical Minute and click enable then say Alexa what's the
0:40.1	news or Alexa what's my flash briefing I hope you'll join us.
0:44.8	Hi everyone this is John Mandrola from the heart dot org medscape
0:50.5	and this is this week in cardiology for February 10th, 2023.
0:55.0	This week I'm going to talk about heart failure with preserved ejection
1:00.0	both drugs and non-drug therapy, the search for atrial fibrillation, exercise as
1:07.8	medicine, and a brief comment about the upcoming ACC. The first piece of news this week was at David Glivelosein, was approved in Europe for any patient with heart failure. the European Commission has expanded the indication for Daph clip-glosen
1:25.9	to include heart failure across the full spectrum of left-intergricher ejection fraction,
1:30.7	including heart failure with mildly reduced and preserved ejection fraction.
1:35.8	The decision was largely made on the basis of the deliver trial.
1:40.1	This was DAPPA versus placebo in Hephpef.
1:44.0	Now I discussed this on the September 1st podcast about five months ago,
1:49.0	but I think it's worth a brief relook again
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.